<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T19:04:00Z</responseDate>
  <request identifier="oai:figshare.com:article/19704419" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/19704419</identifier>
        <datestamp>2026-10-02T17:07:28Z</datestamp>
        <setSpec>category_14</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>portal_87</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>RETRACTED ARTICLE: Sufentanil alleviates pre-eclampsia via silencing microRNA-24-3p to target 11β-Hydroxysteroid dehydrogenase type 2</dc:title>
          <dc:creator>Yang Yue (286377)</dc:creator>
          <dc:creator>Fu Xu (471764)</dc:creator>
          <dc:creator>JiaRong Zhang (12498338)</dc:creator>
          <dc:creator>Miao Zhao (527763)</dc:creator>
          <dc:creator>FangFang Zhou (12498341)</dc:creator>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>sufentanil alleviates pre</dc:subject>
          <dc:subject>target =' _blank</dc:subject>
          <dc:subject>j ., zhao</dc:subject>
          <dc:subject>publication .&lt;/ p</dc:subject>
          <dc:subject>f ., zhang</dc:subject>
          <dc:subject>concerns .&lt;/ p</dc:subject>
          <dc:subject>decision .&lt;/ p</dc:subject>
          <dc:subject>article .&lt;/ p</dc:subject>
          <dc:subject>since publication</dc:subject>
          <dc:subject>significant concerns</dc:subject>
          <dc:subject>target 11β</dc:subject>
          <dc:subject>., xu</dc:subject>
          <dc:subject>therefore retracting</dc:subject>
          <dc:subject>sufficiently address</dc:subject>
          <dc:subject>scholarly record</dc:subject>
          <dc:subject>reported results</dc:subject>
          <dc:subject>remain online</dc:subject>
          <dc:subject>publishing ethics</dc:subject>
          <dc:subject>published work</dc:subject>
          <dc:subject>following article</dc:subject>
          <dc:subject>digitally watermarked</dc:subject>
          <dc:subject>bioengineered &lt;/</dc:subject>
          <dc:subject>2066753 &lt;/</dc:subject>
          <dc:description>&lt;p&gt;We, the Editors and Publisher of the journal &lt;i&gt;Bioengineered&lt;/i&gt;, have retracted the following article from publication.&lt;/p&gt; &lt;p&gt;Yue, Y., Xu, F., Zhang, J., Zhao, M., &amp; Zhou, F. (2022). Sufentanil alleviates pre-eclampsia via silencing microRNA-24-3p to target 11β-Hydroxysteroid dehydrogenase type 2. &lt;i&gt;Bioengineered&lt;/i&gt;, 13(5), 11456–11470. &lt;a target="_blank" href="https://doi.org/10.1080/21655979.2022.2066753"&gt;https://doi.org/10.1080/21655979.2022.2066753&lt;/a&gt;&lt;/p&gt; &lt;p&gt;Since publication, significant concerns have been raised about the integrity of the data and reported results in the article.&lt;/p&gt; &lt;p&gt;When approached for an explanation, the authors provided their original data and answered our queries, but these do not sufficiently address the concerns.&lt;/p&gt; &lt;p&gt;As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors have been informed of this decision.&lt;/p&gt; &lt;p&gt;We have been informed in our decision-making by our policy on publishing ethics and integrity and COPE guidelines.&lt;/p&gt; &lt;p&gt;The retracted article will remain online to maintain the scholarly record and will be digitally watermarked on each page as ‘Retracted’.&lt;/p&gt;</dc:description>
          <dc:date>2022-05-04T09:20:22Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.19704419.v2</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Sufentanil_alleviates_pre-eclampsia_via_silencing_microRNA-24-3p_to_target_11_-Hydroxysteroid_dehydrogenase_type_2/19704419</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
